Icu Medical (ICUI) Total Non-Current Liabilities (2009 - 2026)
Icu Medical's (ICUI) quarterly Total Non-Current Liabilities came in at $1.7 billion in Q2 2026, down 7.75% on a YoY basis from $1.9 billion in Q2 2025, and down 3.91% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Icu Medical (ICUI) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Total Non-Current Liabilities for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 7.75% year-over-year to $1.7 billion; the trailing twelve-month figure through Jun 2026 stood at $1.7 billion (down 7.75% YoY), and the FY2025 full-year result was $1.8 billion, down 15.41% from the prior year.
- Total Non-Current Liabilities eased to $1.7 billion in Q2 2026 per ICUI's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $2.4 billion in Q1 2022 and bottomed at $1.7 billion in Q2 2026.
- Historically, Total Non-Current Liabilities has averaged $2.1 billion across 5 years, with a median of $2.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities jumped 1126.92% in 2022, then retreated 15.41% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $2.3 billion in 2022, then slipped by 6.8% to $2.2 billion in 2023, then rose by 0.81% to $2.2 billion in 2024, then declined by 15.41% to $1.8 billion in 2025, then decreased by 4.83% to $1.7 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.7 billion, $1.8 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 3.68 Bn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 985.45 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 6.34 Bn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 1.75 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.84 Bn |
| Sep 30, 2025 | 1.88 Bn |
| Jun 30, 2025 | 1.90 Bn |
| Mar 31, 2025 | 2.12 Bn |
| Dec 31, 2024 | 2.17 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 2.16 Bn |
| Mar 31, 2024 | 2.12 Bn |
| Dec 31, 2023 | 2.15 Bn |
| Sep 30, 2023 | 2.18 Bn |
| Jun 30, 2023 | 2.24 Bn |
| Mar 31, 2023 | 2.26 Bn |
| Dec 31, 2022 | 2.31 Bn |
| Sep 30, 2022 | 2.23 Bn |
| Jun 30, 2022 | 2.38 Bn |
| Mar 31, 2022 | 2.43 Bn |
| Dec 31, 2021 | 222.88 Mn |
| Sep 30, 2021 | 208.53 Mn |